Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Convergent Ventures is a venture capital firm founded by a diverse team of founders, scientists, and physicians with extensive experience in early-stage investments. Established in San Francisco and New York City, the firm focuses on early-stage teams that utilize science-driven technologies to advance health and sustainability. The founding team’s unique blend of expertise in science and medicine informs their investment strategy, allowing them to identify and support innovative startups.
The firm operates primarily in North America, targeting sectors such as healthcare, biotech, and climate. Convergent Ventures emphasizes collaboration with other investors to enhance market and technical expertise, which is crucial for the success of their portfolio companies. Their commitment to science-driven technologies positions them as a key player in the early-stage investment landscape.
Convergent Ventures invests in differentiated technologies at the intersection of data and the natural, physical, and human sciences. Their investment strategy encompasses a range of sectors, including healthcare, biotech, and climate, with a strong emphasis on scalable business models that can deliver significant societal impacts alongside financial returns. The firm specifically targets pre-seed, seed, seed-plus, and Series A funding rounds, making them a suitable partner for early-stage startups.
Collaboration is a cornerstone of Convergent Ventures' approach, as they prefer to work alongside multiple investors to bolster their market and technical expertise. This collaborative strategy not only enhances the support provided to portfolio companies but also fosters a network of resources that can be invaluable for startups navigating complex challenges in health and sustainability.
Convergent Ventures has built a notable portfolio of companies that exemplify their focus on science-driven technologies. Key portfolio companies include:
This diverse portfolio reflects Convergent Ventures' commitment to investing in technologies that not only promise financial returns but also contribute positively to society.
Julia Davourie, MEng: Co-Founder and General Partner. Julia has a background in engineering and has led numerous early-stage investments in health and sustainability.
Christina Jenkins, MD: Co-Founder and General Partner. Christina brings medical expertise to the firm, having worked in various healthcare settings prior to her venture capital career.
Frank Levinson, PhD: Co-Founder and General Partner. Frank has a strong background in science and technology, contributing to the firm’s focus on data-driven investments.
Mark Alderman, Esq: Advisor. Mark provides legal expertise and guidance on regulatory matters affecting portfolio companies.
Dave Clarke: Advisor. Dave has extensive experience in the startup ecosystem, offering strategic insights to portfolio founders.
Jennifer Fried: Advisor. Jennifer specializes in healthcare investments and brings a wealth of knowledge in the sector.
Dan Gold, PhD: Advisor. Dan’s scientific background supports the firm’s focus on technology-driven investments.
Zach Jonasson, PhD: Advisor. Zach provides expertise in data science and analytics, enhancing the firm’s investment approach.
Bryan Lawlis, PhD: Advisor. Bryan has a strong background in biotechnology, contributing to the firm’s focus on health-related investments.
Dan Riff: Advisor. Dan offers insights into market trends and investment strategies.
What investment criteria does Convergent Ventures use?
Convergent Ventures focuses on early-stage teams that leverage science-driven technologies in sectors such as healthcare, biotech, and climate. They seek scalable business models that can deliver significant societal impacts and financial returns.
How can founders apply or pitch to Convergent Ventures?
Founders interested in pitching to Convergent Ventures are encouraged to reach out through their website. Specific contact details are not provided, but they welcome inquiries from potential portfolio companies.
What makes Convergent Ventures different from other investors?
The firm emphasizes collaboration with multiple investors to enhance market and technical expertise, which is a distinctive aspect of their investment strategy. This collaborative approach allows them to provide more comprehensive support to their portfolio companies.
What is the geographic scope of Convergent Ventures?
Convergent Ventures primarily focuses on the North American market, investing in early-stage companies based in this region.
What is the typical check size for investments?
While specific check sizes are not disclosed, Convergent Ventures targets pre-seed, seed, seed-plus, and Series A funding rounds, indicating a range of investment amounts suitable for early-stage startups.
What kind of post-investment involvement can founders expect?
Convergent Ventures provides ongoing support to their portfolio companies, leveraging their extensive network and expertise in science-driven technologies to assist in navigating challenges and scaling operations.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.